5th Annual Biomarkers Congress, 25 - 26 February 2010
Midland Hotel
Peter Street
MANCHESTER M60 2DS
The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates. To stay competitive, they are re-evaluating their drug development process to reduce attrition rates. Biomarkers promise to transform drug discovery, clinical development and molecular diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity.
The 5th Annual Biomarkers Congress 2010 provides a first class educational and networking opportunity for over 200 attendees to gain knowledge and insights into the Biomarkers marketplace. Do not miss out on the opportunity to learn insights on how you can streamline your R&D process and identify potential cost savings through successful biomarker discovery, validation and clinical development. Over the two days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 50 senior level industry speakers from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions.
For more information please visit the event website http://www.biomarkers-congress.com/